The passage of the Inflation Reduction Act gave Medicare the power to negotiate prices for certain drugs — and pegging those prices to ICER’s value estimates could save billions of dollars, according to a paper published late last week.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,